|
Post by ilovekauai on May 2, 2016 13:11:23 GMT -5
Well I read it, and begrudgingly have to give the guy credit for managing to make a living out of very questionable "journalism" on the biotech industry. His dislike of MNKD is evident, goes way beyond the pale, and question if he is mentally balanced; a legend in his own mind kinda deal. I stopped reading his attack articles, those of The Street, SA, on MNKD years ago. They just spread FUD for whatever reason(s) we may wish to speculate on.
|
|
|
Post by ilovekauai on Apr 26, 2016 13:26:14 GMT -5
Have one for me. Way too early out here on Kauai for a Mai Tai...
|
|
|
Post by ilovekauai on Apr 24, 2016 15:56:13 GMT -5
Excuse my naivety, but how are all these new positions being funded? Did I miss something on this? Just wondering where the cash is coming from. Was it the Shelf Registration or some other vehicle? Btw, I'm all for this and excited about the possibilities of where this can take Afrezza. Mahalo.
|
|
|
Post by ilovekauai on Apr 18, 2016 14:17:36 GMT -5
This is fantastic news and very impressive stuff. Mahalo to all for posting this. Most excellent! I'm going to add to my position right now. We may not see results from this till later this year, but it's coming. IMO, we're finally turning the corner; Sanofi is firmly in the rearview mirror, and we control our own destiny.
IMO, the more I think about it, the more I realize that Sanofi never saw us as a partner, but instead as a direct threat that would cannibalize their own in-house, diabetic medicines. Everything changed with them when the new CEO came on board; Sanofi overpriced Afrezza on purpose to prevent broad based insurance coverage, did very limited/bare bone marketing by contract, and instructed their sales reps to make Afrezza a low-priority on their calls.
This begs the question why? IMO it was because Sanofi never was happy with a 65/35% split on the profits, and with a successful launch of Afrezza, MNKD share price would soar to compete with the SNY share price. That scared the bejeebees out of Sanofi. How would a SNY shareholder feel if that happened? IMO Sanofi tried to bankrupt MNKD and failed. And now today, we're still here; free, independent, on our way to future profitability, and will greatly help millions of diabetics worldwide. I never stopped believing in the blockbuster potential of Afrezza having a global impact. This drug will change the way diabetics relate to their disease, including me. Aloha.
|
|
|
Post by ilovekauai on Apr 15, 2016 13:08:38 GMT -5
Well, over the years if there's one thing I've learned from this stock; is to expect the unexpected. I'm curious as to what unfolds next Tuesday at the CC. Such a wild ride this holding has been with more "thrills" in the future I suspect. Have a great weekend all. Aloha.
|
|
|
Post by ilovekauai on Apr 13, 2016 21:35:02 GMT -5
Mahalo KC. It's nice to be back for the long march ahead to profitability.
|
|
|
Post by ilovekauai on Apr 13, 2016 13:26:49 GMT -5
Yes, I elected to start posting again. Mahalo for asking.
|
|
|
Post by ilovekauai on Apr 13, 2016 13:18:53 GMT -5
I could not resist and added more today. Looking forward to the Tuesday CC, to see where the long path back leads. Aloha.
|
|